Ikena Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	63	95	96	450	-
Market Cap Growth	-	-1.43%	-78.58%	-	-
Enterprise Value	-102	-70	-55	225	-162
PE Ratio	-1.39	-1.39	-1.40	-13.20	-
PS Ratio	6.85	10.38	6.18	14.53	-
PB Ratio	0.37	0.56	0.66	2.17	-
P/FCF Ratio	-1.19	-1.19	-1.28	-7.26	-
P/OCF Ratio	-1.19	-1.19	-1.30	-7.47	-
EV/Sales Ratio	-7.60	-7.60	-3.51	7.26	-17.65
EV/EBITDA Ratio	1.06	1.06	0.82	-6.95	3.78
EV/EBIT Ratio	1.02	1.02	0.80	-6.60	3.67
EV/FCF Ratio	0.87	0.87	0.73	-3.63	4.21
Debt / Equity Ratio	0.06	0.06	0.04	0.03	0.00
Debt / EBITDA Ratio	-0.16	-0.16	-0.09	-0.22	0.00
Debt / FCF Ratio	-0.13	-0.13	-0.08	-0.11	0.00
Quick Ratio	12.35	12.35	7.30	8.54	5.74
Current Ratio	12.58	12.58	7.44	8.70	5.86
Asset Turnover	0.05	0.05	0.08	0.12	0.07
Return on Equity (ROE)	-44.20%	-44.20%	-40.90%	-16.00%	54.50%
Return on Assets (ROA)	-37.30%	-37.30%	-34.30%	-12.60%	-34.80%
Return on Capital (ROIC)	-41.78%	-41.78%	-46.44%	-15.89%	44.14%
Earnings Yield	-108.66%	-71.70%	-71.30%	-7.58%	-
FCF Yield	-127.77%	-84.32%	-78.32%	-13.77%	-
Buyback Yield / Dilution	-15.33%	-15.33%	-29.32%	-911.88%	-4.43%
Total Shareholder Return	-15.33%	-15.33%	-29.32%	-911.88%	-4.43%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).